Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
This locus encodes the transforming growth factor (TGF)-beta type III receptor. Zusätzlich bieten wir Ihnen TGFBR3 Kits (17) und TGFBR3 Proteine (10) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 145 products:
Human Polyclonal TGFBR3 Primary Antibody für CyTOF, FACS - ABIN4899613
Bandyopadhyay, Zhu, Malik, Kreisberg, Brattain, Sprague, Luo, López-Casillas, Sun: Extracellular domain of TGFbeta type III receptor inhibits angiogenesis and tumor growth in human cancer cells. in Oncogene 2002
Show all 7 Pubmed References
Human Polyclonal TGFBR3 Primary Antibody für IHC, IHC (p) - ABIN4359082
Kato, Nicholson, Neiman, Rantalainen, Holmes, Barrett, Uhlén, Nilsson, Spector, Schwenk: Variance decomposition of protein profiles from antibody arrays using a longitudinal twin model. in Proteome science 2011
Show all 3 Pubmed References
Human Monoclonal TGFBR3 Primary Antibody für ELISA, WB - ABIN1724752
Jiang, Liu, Lei, You, Zhou, Zhang: [Defective expression of TGFBR3 gene and its molecular mechanisms in non-small cell lung cancer cell lines]. in Zhongguo fei ai za zhi = Chinese journal of lung cancer 2010
Show all 2 Pubmed References
Human Monoclonal TGFBR3 Primary Antibody für FACS, ELISA - ABIN1724751
Lambert, Huang, Mythreye, Blobe: The type III transforming growth factor-? receptor inhibits proliferation, migration, and adhesion in human myeloma cells. in Molecular biology of the cell 2011
Show all 2 Pubmed References
Human Polyclonal TGFBR3 Primary Antibody für ELISA - ABIN449737
Woszczyk, Gola, Jurzak, Mazurek, Myka?a-Cie?la, Wilczok: Expression of TGF beta1 genes and their receptor types I, II, and III in low- and high-grade malignancy non-Hodgkin's lymphomas. in Medical science monitor : international medical journal of experimental and clinical research 2004
Human Polyclonal TGFBR3 Primary Antibody für FACS - ABIN4896383
Reinartz, Finkernagel, Adhikary, Rohnalter, Schumann, Schober, Nockher, Nist, Stiewe, Jansen, Wagner, Müller-Brüsselbach, Müller: A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome. in Genome biology 2016
Human Polyclonal TGFBR3 Primary Antibody für FACS - ABIN4896384
Wang, Yu, Sarnaik, Yu, Hall, Morelli, Zhang, Zhao, Weber: Biomarkers on melanoma patient T cells associated with ipilimumab treatment. in Journal of translational medicine 2012
Inhibition of genes for betaglycan and FIBP (zeige FIBP Antikörper) in granulosa cells in vitro suggests that they inhibit estradiol production in regressing subordinate follicles.
describe a detailed characterization of TbetaRIII expression in lymphocyte subpopulations demonstrating that this co-receptor is significantly expressed in T but not B lymphocytes and among them, preferentially expressed on naive and central memory T cells
TGF-beta (zeige TGFB1 Antikörper) type I, II, and III receptors were all identified in pregnant serum; all were substantially elevated in early-onset but not late-onset PE. Endoglin (zeige ENG Antikörper) was increased in both subtypes.
TGFBR3 and/or MGEA5 (zeige MGEA5 Antikörper) rearrangements are much more common in hybrid hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas.
opposing functions for the different GAG modifications on TbetaRIII suggesting that Wnt (zeige WNT2 Antikörper) interactions with the TbetaRIII heparan sulfate chains result in inhibition of Wnt (zeige WNT2 Antikörper) signaling, likely via Wnt (zeige WNT2 Antikörper) sequestration, whereas the chondroitin sulfate GAG chains on TbetaRIII promote Wnt3a (zeige WNT3A Antikörper) signaling.
Results suggest that high expression levels of alpha-inhibin and beta-glycan transcripts in secretory phase endometrium are associated with a lower chance of achieving pregnancy with in vitro fertilization.
Results show decreased TbetaRIII expression with hepatocellullar carcinoma (HCC (zeige FAM126A Antikörper)) progression leading to the activation of Smad2 (zeige SMAD2 Antikörper) and suggest that TbetaRIII acts as a suppressive factor in regulating the migration and invasion of HCC (zeige FAM126A Antikörper), by inhibiting Smad2 (zeige SMAD2 Antikörper) and Akt (zeige AKT1 Antikörper) pathways.
Study shows that TbetaRIII expression is significantly decreased in salivary glands adenoid cystic carcinoma (ACC) patients and defines TbetaRIII as a biomarker exerting antitumor action on ACC progression.
No correlation of loss of heterozygosity at the TGFBR3 locus with clinicopathological parameters suggests that allelic imbalance may be an early genetic event during neoplastic transformation of human endometrium.
Study shows that GDF10 (zeige GDF10 Antikörper) is down-regulated in patients with oral squamous cell carcinoma, and is an independent risk factor for overall survival. Its expression is regulated by TGFBR3 which shares the signaling inhibiting epithelial-mesenchymal transition.
rs1192415 of TGFBR3 is associated with primary open angle glaucoma.
TGFbetaR3 promotes apoptosis of cardiomyocytes via a p38 (zeige CRK Antikörper) pathway-associated mechanism, and loss of TGFbetaR3 reduces myocardial infarction injury.
BMP2 (zeige BMP2 Antikörper) also requires Src (zeige SRC Antikörper) for filamentous actin polymerization in Tgfbr3(-/-) epicardial cells.
Study identified a novel major binding site for TGF-beta (zeige TGFB1 Antikörper)-like growth factors in TGFR-3. Findings potentially provide novel experimental insight into the general function of zona pellucida domain-containing proteins.
Retinoic acid enhanced TbetaRIII expression and that this increase contributed to LF-stimulated IgA (zeige IgA Antikörper) production.
Pro-fibrotic cardiac effect of miR (zeige MLXIP Antikörper)-328 was mediated by down-regulating TGFbR3 and up-regulating TGFb1 (zeige TGFB1 Antikörper).
These data demonstrate that TbetaRIII regulates BMP-mediated signaling and biological effects, primarily through the ligand sequestration effects of sTbetaRIII in normal and cancerous mammary epithelial cells.
Glucocorticoids recruit Tgfbr3 and Smad1 (zeige SMAD1 Antikörper) to shift transforming growth factor-beta signaling from the Tgfbr1 (zeige TGFBR1 Antikörper)/Smad2 (zeige SMAD2 Antikörper)/3 axis to the Acvrl1 (zeige ACVRL1 Antikörper)/Smad1 (zeige SMAD1 Antikörper) axis in lung fibroblasts.
work reveals a 'seed and soil' mechanism where TGF-beta2 (zeige TGFB2 Antikörper) and TGF-beta (zeige TGFB1 Antikörper)-RIII signalling through p38alpha (zeige MAPK14 Antikörper)/beta regulates DTC dormancy and defines restrictive (BM) and permissive (lung) microenvironments for HNSCC metastasis
TGFBR3 mediated suppression of cancer progression includes effects on the tumor immune microenvironment.
This study provides evidence that the expressions of inhibin alpha subunit (zeige INHA Antikörper) and betaglycan are inferior in cystic follicles, and this may be caused by the decrease in FSH (zeige BRD2 Antikörper) in the presence of a cystic follicle.
This locus encodes the transforming growth factor (TGF)-beta type III receptor. The encoded receptor is a membrane proteoglycan that often functions as a co-receptor with other TGF-beta receptor superfamily members. Ectodomain shedding produces soluble TGFBR3, which may inhibit TGFB signaling. Decreased expression of this receptor has been observed in various cancers. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene.
transforming growth factor, beta receptor III
, transforming growth factor, beta receptor III (betaglycan, 300kDa)
, transforming growth factor beta receptor type 3-like
, TGF-beta receptor type 3
, TGF-beta receptor type III
, betaglycan proteoglycan
, transforming growth factor beta receptor type 3
, transforming growth factor, beta receptor 3
, TGF-beta type III receptor
, transforming growth factor beta receptor III
, transforming growth factor-beta type III receptor